REDUCE-IT: CV Benefit Directly Related to EPA Levels REDUCE-IT: CV Benefit Directly Related to EPA Levels

The benefits with icosapent ethyl cannot be explained by the degree of changes to triglycerides or other biomarkers such as LDL or CRP, a new analysis shows.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news